In our current pilot study with the limitation of small sample size, RA was not associated with an increased risk of CAD in our RA patients who were in remission. Larger studies of CAD in Asian RA patients are needed to confirm our current finding.
IJN. Among the parameters reviewed were pacing thresholds and impedances, pacing stability as well as development of pacing related complications. Electrical performances were tracked from the point of implant to successful completion of 1-year follow up. Results: Between March 2014 to January 2018, 192 patients were subjected to procedural attempt to implant a Miera TPS for various indications. Out of these 192 patients, the Miera was successfully implanted in 190 patients (99%). 113 (59.5%) have completed 1-year follow-up. The mean age of these patients is 73.3±10.5 years old. 60 (53.1%) patients were female and 53 (46.9%) patients were male. The most common indication for Miera implantation was for complete heart block (27.4%). Early complications were bleeding in 1 patient (0.9%) and elevated capture threshold post implant in 1 patient (0.9%). 1 patient (0.9%) develop pacemaker related infection at 1 month needing extraction of the Miera pacemaker. Electrical performance was good from the point of implant to over 1-year period with stable threshold (1.7 at implant vs 2.0 at 1-year, p value=0.298). There were no late complications such as perforation or pericardia! effusion at 1-year. Conclusion: The Miera TPS leadless pacing system showed a high degree of efficacy and efficiency at 1-year follow-up.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.